Palomar Holdings, Inc. (NASDAQ:PLMR) Given Average Recommendation of “Moderate Buy” by Analysts

Palomar Holdings, Inc. (NASDAQ:PLMR) has received an average rating of “Moderate Buy” from the eight research firms that are covering the firm, MarketBeat reports. One analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $158.1429.

Several equities analysts recently weighed in on the stock. Keefe, Bruyette & Woods raised their target price on shares of Palomar from $170.00 to $171.00 and gave the company an “outperform” rating in a research note on Tuesday, January 6th. Wall Street Zen lowered shares of Palomar from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. Evercore ISI initiated coverage on shares of Palomar in a research note on Monday. They issued an “outperform” rating and a $150.00 target price for the company. JPMorgan Chase & Co. upped their price objective on Palomar from $145.00 to $155.00 and gave the company an “overweight” rating in a research note on Wednesday, January 7th. Finally, Weiss Ratings upgraded Palomar from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, January 14th.

Palomar Price Performance

Shares of NASDAQ PLMR opened at $127.01 on Friday. Palomar has a fifty-two week low of $107.75 and a fifty-two week high of $175.85. The stock has a market capitalization of $3.37 billion, a price-to-earnings ratio of 17.69 and a beta of 0.44. The business has a 50-day moving average of $128.42 and a 200-day moving average of $123.23.

Palomar (NASDAQ:PLMR) last issued its quarterly earnings results on Wednesday, February 11th. The company reported $2.24 EPS for the quarter, beating the consensus estimate of $2.06 by $0.18. The firm had revenue of $492.63 million during the quarter, compared to analysts’ expectations of $204.58 million. Palomar had a return on equity of 23.48% and a net margin of 22.50%.The business’s quarterly revenue was up 62.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.52 earnings per share. On average, sell-side analysts expect that Palomar will post 5.99 EPS for the current year.

Key Stories Impacting Palomar

Here are the key news stories impacting Palomar this week:

• Positive Sentiment: Q4 beats and raised 2026 guidance — Palomar reported adjusted EPS of $2.24 (beat) and strong revenue/premium growth; management gave a full‑year 2026 adjusted net income outlook of $260M–$275M, signaling confidence in continued growth. Palomar Q4 Earnings & Revenues Beat Estimates, Premiums Rise Y/Y
• Positive Sentiment: Strong underlying growth — Gross written premiums rose ~31–32% in Q4 and FY2025; full‑year adjusted net income jumped ~62% year‑over‑year, showing scale from acquisitions and product expansion. Palomar Holdings, Inc. Reports Strong Fourth Quarter and Full Year 2025 Results
• Neutral Sentiment: New analyst/institutional attention — Evercore ISI initiated coverage and industry write‑ups compare Palomar to peers (e.g., Root), which may increase trading interest but not directly change fundamentals. Evercore ISI Initiates Coverage on Palomar (NASDAQ:PLMR)
• Neutral Sentiment: Earnings writeups and call availability — Multiple outlets summarized the results and the company hosted a conference call; listen for management commentary on loss trends and M&A execution. MarketBeat Q4 Summary & Conference Call
• Negative Sentiment: Underwriting metrics deteriorated — Q4 total loss ratio rose to 30.4% (from 25.7% a year ago) and the adjusted combined ratio widened to ~73–74% (vs. ~71–72% prior). Rising non‑catastrophe losses and a higher combined ratio create concern that margin expansion may be harder to sustain. Compared to Estimates, Palomar (PLMR) Q4 Earnings: A Look at Key Metrics
• Negative Sentiment: Spike in non‑cat losses and notable insider/institutional selling — Reports flag a large increase in non‑catastrophe losses and heavy insider sales activity (many insider sales vs. few purchases), plus several large funds trimmed positions — a catalyst for profit‑taking. Quiver Quant: Q4 Results, Loss Trends, Insider/Institutional Activity

Insider Activity

In other news, President Jon Christianson sold 1,991 shares of the business’s stock in a transaction dated Wednesday, January 28th. The shares were sold at an average price of $119.88, for a total value of $238,681.08. Following the completion of the sale, the president owned 62,985 shares of the company’s stock, valued at approximately $7,550,641.80. The trade was a 3.06% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Mac Armstrong sold 11,484 shares of the stock in a transaction that occurred on Wednesday, January 28th. The stock was sold at an average price of $119.88, for a total transaction of $1,376,701.92. Following the transaction, the chief executive officer owned 91,737 shares in the company, valued at approximately $10,997,431.56. The trade was a 11.13% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 58,998 shares of company stock valued at $7,255,669. 3.70% of the stock is owned by insiders.

Institutional Trading of Palomar

A number of institutional investors have recently modified their holdings of PLMR. Invesco Ltd. boosted its position in shares of Palomar by 234.1% during the 2nd quarter. Invesco Ltd. now owns 798,361 shares of the company’s stock worth $123,147,000 after acquiring an additional 559,383 shares in the last quarter. Alliancebernstein L.P. raised its position in Palomar by 290.2% during the second quarter. Alliancebernstein L.P. now owns 497,080 shares of the company’s stock valued at $76,675,000 after purchasing an additional 369,697 shares in the last quarter. Westfield Capital Management Co. LP lifted its stake in Palomar by 81.0% during the third quarter. Westfield Capital Management Co. LP now owns 738,528 shares of the company’s stock worth $86,223,000 after purchasing an additional 330,592 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. boosted its holdings in shares of Palomar by 72.1% in the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 785,165 shares of the company’s stock valued at $105,809,000 after purchasing an additional 328,993 shares in the last quarter. Finally, AustralianSuper Pty Ltd acquired a new stake in shares of Palomar in the 2nd quarter valued at $37,253,000. 90.25% of the stock is currently owned by institutional investors.

About Palomar

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.